391 related articles for article (PubMed ID: 27578074)
1. Itch Management: Treatments under Development.
Pereira MP; Ständer S
Curr Probl Dermatol; 2016; 50():71-6. PubMed ID: 27578074
[TBL] [Abstract][Full Text] [Related]
2. Drugs on the Horizon for Chronic Pruritus.
McEwen MW; Fite EM; Yosipovitch G; Patel T
Dermatol Clin; 2018 Jul; 36(3):335-344. PubMed ID: 29929605
[TBL] [Abstract][Full Text] [Related]
3. Small molecule drugs for the treatment of pruritus in patients with atopic dermatitis.
Soeberdt M; Kilic A; Abels C
Eur J Pharmacol; 2020 Aug; 881():173242. PubMed ID: 32504692
[TBL] [Abstract][Full Text] [Related]
4. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
[TBL] [Abstract][Full Text] [Related]
5. Emerging Therapeutic Options for Chronic Pruritus.
Reszke R; Krajewski P; Szepietowski JC
Am J Clin Dermatol; 2020 Oct; 21(5):601-618. PubMed ID: 32607945
[TBL] [Abstract][Full Text] [Related]
6. Itch Management: Systemic Agents.
Pongcharoen P; Fleischer AB
Curr Probl Dermatol; 2016; 50():46-53. PubMed ID: 27578071
[TBL] [Abstract][Full Text] [Related]
7. [Pruritus in systemic diseases : Common and rare etiologies].
Kremer AE; Mettang T
Internist (Berl); 2019 Aug; 60(8):814-820. PubMed ID: 31243493
[TBL] [Abstract][Full Text] [Related]
8. Management of Chronic Hepatic Itch.
Düll MM; Kremer AE
Dermatol Clin; 2018 Jul; 36(3):293-300. PubMed ID: 29929600
[TBL] [Abstract][Full Text] [Related]
9. Upcoming topical TRPV1 anti-pruritic compounds.
Lee KP; Koshelev MV
Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054935
[TBL] [Abstract][Full Text] [Related]
10. Novel drugs for the treatment of chronic pruritus.
Pereira MP; Ständer S
Expert Opin Investig Drugs; 2018 Dec; 27(12):981-988. PubMed ID: 30426802
[TBL] [Abstract][Full Text] [Related]
11. Emerging drugs for the treatment of pruritus.
Ständer S; Weisshaar E; Raap U
Expert Opin Emerg Drugs; 2015 Sep; 20(3):515-21. PubMed ID: 26027744
[TBL] [Abstract][Full Text] [Related]
12. Prurigo Nodularis and Its Management.
Zeidler C; Yosipovitch G; Ständer S
Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592
[TBL] [Abstract][Full Text] [Related]
13. Development of PAC-14028, a novel transient receptor potential vanilloid type 1 (TRPV1) channel antagonist as a new drug for refractory skin diseases.
Lim KM; Park YH
Arch Pharm Res; 2012 Mar; 35(3):393-6. PubMed ID: 22477184
[TBL] [Abstract][Full Text] [Related]
14. Use of Butorphanol as Treatment for Cholestatic Itch.
Golpanian RS; Yosipovitch G; Levy C
Dig Dis Sci; 2021 May; 66(5):1693-1699. PubMed ID: 32556969
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis and treatment of pruritus in cholestasis.
Kremer AE; Beuers U; Oude-Elferink RP; Pusl T
Drugs; 2008; 68(15):2163-82. PubMed ID: 18840005
[TBL] [Abstract][Full Text] [Related]
16. Pruritus in Cutaneous T-Cell Lymphoma and Its Management.
Serrano L; Martinez-Escala ME; Zhou XA; Guitart J
Dermatol Clin; 2018 Jul; 36(3):245-258. PubMed ID: 29929596
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulating Agents as Antipruritics.
Erickson S; Nahmias Z; Rosman IS; Kim BS
Dermatol Clin; 2018 Jul; 36(3):325-334. PubMed ID: 29929604
[TBL] [Abstract][Full Text] [Related]
18. Prurigo Nodularis Management.
Tsianakas A; Zeidler C; Ständer S
Curr Probl Dermatol; 2016; 50():94-101. PubMed ID: 27578077
[TBL] [Abstract][Full Text] [Related]
19. Substance P and neurokinin 1 receptor are new targets for the treatment of chronic pruritus.
Ständer S; Yosipovitch G
Br J Dermatol; 2019 Nov; 181(5):932-938. PubMed ID: 31016733
[TBL] [Abstract][Full Text] [Related]
20. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions.
Kremer AE; van Dijk R; Leckie P; Schaap FG; Kuiper EM; Mettang T; Reiners KS; Raap U; van Buuren HR; van Erpecum KJ; Davies NA; Rust C; Engert A; Jalan R; Oude Elferink RP; Beuers U
Hepatology; 2012 Oct; 56(4):1391-400. PubMed ID: 22473838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]